Head Of U.S. National Institutes Of Health Warns Court Ban On Funding For Embryonic Stem Cell Research Could Trigger Flight Of Best Scientists To Rival Centers Abroad
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As lawyers for the United States Department of Justice and for those seeking to halt all federal funding for embryonic stem cell research prepare for a new round of battle in a U.S. Court of Appeals, the head of the National Institutes of Health is warning that a funding freeze could trigger an exodus of the best embryonic stem cell scientists to rival centers abroad